EUCTR2011-000064-10-AT进行中（未招募）不适用
Target site pharmacokinetics of linezolid or tigecycline in patients with severe skin and skin structure infections (SSSI) associated with chronic fistulas. - Fistula-SD-MD
Med. Univ. Wien, Klinik für klinische Pharmakologie0 个研究点目标入组 20 人开始时间: 2011年2月16日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Male or female, aged between 18 and 90 years
- •Clinically diagnosis of chronic fistulas as caused by hidradenitis suppurativa or other chronic processes
- •Willingness and ability to comply with the protocol
- •Signed informed consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Allergy or hypersensitivity against study drug
- •Contraindications for use of study drug
- •Severe renal impairment Severe hepatic impairment (Child-Pugh Class C)
- •Pregnancy, or women of child bearing potential not willing to apply adequate contraception during study period
- •Any disease considered relevant for proper performance of the study or risks to the patient, at the discretion of the investigator
研究者
相似试验
进行中（未招募）
1 期
Target site pharmacokinetics of linezolid after repetitive doses in diabetic patients with bacterial foot infectioThe study population will consist of a representative group of adult male or female patients with documented diabetes and bacterial soft tissue infection of the foot complicated by osteomyelitis. Patients must be subjected to undergo surgical debridement and intravenous antimicrobial therapy.EUCTR2008-006153-41-ATMedical university Graz, Department of Plastic Surgery
进行中（未招募）
不适用
Target site pharmacokinetics of linezolid after single and multiple doses in diabetes patients with soft tissue infectiodiabetic patients with soft tissue infection, necessiting antibiotic therapyEUCTR2007-007958-54-ATDepartment of Clinical Pharmacology, Medical University of Vienna
进行中（未招募）
不适用
Investigation of the blood levels of selected antibiotics in critically ill patients undergoing dialysisSepsis and acute renal failure (ARF) are pathological entities that commonly co-exist in patients admitted to intensive care. Antibiotic dosing in septic patients with ARF can be complicated and may result in either underdosing, causing treatment failure and antibiotic resistance, or overdosing resulting in drug toxicity. The aim of this study is to collect pharmacokinetic data for evaluating underdosing or overdosing of linezolid and meropenem in patients receiving renal replacement therapy.EUCTR2013-000899-16-DEDepartment of Pharmacy Unversitätsmedizin Mainz
已完成
1 期
Linezolid Pharmacokinetics (PK) in Multi-Drug Resistant (MDR)/Extensively-Drug Resistant (XDR) Tuberculosis (TB)Multi-Drug Resistant TuberculosisExtensively Drug Resistant TuberculosisNCT00691392Centers for Disease Control and Prevention26
尚未招募
4 期
pharmacokinetics and toxicity of linezolid in MDR-TB patientstuberculosis MDR-TB10028440NL-OMON29905niversitair Medisch Centrum Groningen10